About this episodeC60 EVO is conducting publishable clinical trials on the ESS60 molecule to validate its effects on severe head…AI summary
C60 EVO is conducting publishable clinical trials on the ESS60 molecule to validate its effects on severe headaches, systemic inflammation (hs-CRP), sleep, and skin aging, driven by strong anecdotal evidence. The molecule works by entering mitochondria to buffer oxidative stress, with one drop containing 400 times more molecules than the number of cells in the human body. The company offers specific subscriber discounts and product bundles for viewers while running a giveaway for three winners.
Key takeaways 6
ESS60 Molecule Mechanism: The ESS60 molecule enters mitochondria and can hold up to six negatively charged particles (reactive oxygen species), acting as a buffer against oxidative stress. This is critical because modern life stresses mitochondria, leading to damage that resident antioxidants like glutathione and melatonin cannot fully manage alone.
Longevity Research Data: In a peer-reviewed study using Wistar rats, the ESS60 molecule resulted in a 90% extension of life (living 62 months vs. 32 months) and zero tumor development, representing the single longest longevity experimental result on mammals in history.
Clinical Trial Focus Areas: The company is launching four specific publishable trials: 1) Frequent and severe headaches, 2) hs-CRP (inflammatory marker for cardiovascular disease/cancer), 3) Formalized sleep study, and 4) Wrinkle and age spot study using a two-part solution of ESS60 and UTH29 peptide.
Dosage Potency: One drop of the formula contains 400 times as many ESS60 molecules as there are cells in the human body, designed to achieve saturation levels necessary to impact the 50-5,000 mitochondria per cell (and 2 million in brain cells).
Product Safety Distinction: The product uses ESS60 manufactured in a lab in Houston, Texas, distinct from industrial-grade C60 from China used for ink/tires. The formula is mixed in stainless steel urns for three weeks with specific temperature and light controls.
Subscription Success Rate: 71% of sales come from subscribers and resubscribers, indicating high retention and perceived efficacy among users.
Notable quotes 5AI-generated: wording and quote attribution may be wrong. Use the play link to verify.
“When I started taking this product on a regular basis at the beginning of 2018, I went for 18 months without getting a single one of these headaches.”
▶ 0:17Chris Burrus sharing his personal spreadsheet data on severe headaches before and after using the product.
“One drop has 400 times as many of these ESS60 molecules in it as you have cells in your body.”
▶ 19:34Explaining the potency required to saturate mitochondria across the body's cells.
“The halo was starting. I knew it was coming on... That little droplet that I took out of the lid changed everything. The halo went away. It never came back.”
▶ 18:39Gary Franchie's live-on-air testimonial of stopping a migraine by licking the lid of the bottle after running out of product.
“We believe we're reducing the negative impact of stressed mitochondria... if you reduce that negative impact... you should have systemic benefits.”
▶ 8:01Chris Burrus explaining the 'BOSS' (Buffering Oxidative Stress System) theory behind the product's efficacy.
“The FDA has not evaluated our product. It is not intended to treat, diagnose, cure, or prevent any disease.”
▶ 14:20Standard disclaimer provided when discussing health benefits and clinical trials.
Chapters & Sections (16)▼
0:00C60 Clinical Trials and Longevity Researchchapter1
2:13C60 Clinical Trials and Longevity Research
5:51Mitochondrial Stress and ESS60 Mechanismchapter2
8:40Cellular Detoxification and Mitochondrial Benefits
10:26Clinical Trials and FDA Rigor
12:00C60 EVO Severe Headache Relief Testimonialschapter2
1h 17m
39m
29m
42m
59m⏭ 1
34m⏭ 1
2h 31m⏭ 2
15m⏭ 2
1h 31m⏭ 1
2h 5m⏭ 2
1h 9m
59m⏭ 4
1h 30m⏭ 9
1h 1m⏭ 1
1h 33m⏭ 2
2h 7m⏭ 1
2h 41m⏭ 2
1h 28m⏭ 1
1h 0m⏭ 1
33m
46m
3h 54m⏭ 7
3h 59m⏭ 5
1h 13m
54m⏭ 1
54m⏭ 2
58m⏭ 5
25m
45m⏭ 2
1h 16m⏭ 2